Brief ReportsIsotretinoin Plus Clindamycin Seem Highly Effective Against Severe Erlotinib-Induced Skin Rash in Advanced Non-small Cell Lung Cancer
Under an Elsevier user license
open archive
Key Words:
Isotretinoin
Clindamycin
Erlotinib
Skin rash
Non-small cell lung cancer
Cited by (0)
Disclosure: The authors declare no conflicts of interest.
Copyright © 2010 International Association for the Study of Lung Cancer. All rights reserved.